Perioperative Vorasidenib and Ivosidenib Remain Effective, Safe in IDH1+ Diffuse Glioma
Mirdametinib Improves HRQOL in Adult and Pediatric Patients With NF1-PN
Dr Schiff on PFS and OS Data With Temozolomide Plus Radiation in Grade II Glioma
Larotrectinib Induces Rapid, Durable Responses in Pediatric Patients With TRK Fusion+ CNS Tumors